391 related articles for article (PubMed ID: 25200065)
1. Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.
Zhang D; Sun B; Zhao X; Ma Y; Ji R; Gu Q; Dong X; Li J; Liu F; Jia X; Leng X; Zhang C; Sun R; Chi J
Mol Cancer; 2014 Sep; 13():207. PubMed ID: 25200065
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
[TBL] [Abstract][Full Text] [Related]
3. Twist1 accelerates tumour vasculogenic mimicry by inhibiting Claudin15 expression in triple-negative breast cancer.
Zhang D; Sun B; Zhao X; Sun H; An J; Lin X; Zhu D; Zhao X; Wang X; Liu F; Zhang Y; Liu J; Gu Q; Dong X; Qiu Z; Liu Z; Qi H; Che N; Li J; Cheng R; Zheng X
J Cell Mol Med; 2020 Jul; 24(13):7163-7174. PubMed ID: 32469152
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.
Tao W; Sun W; Zhu H; Zhang J
Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
Shin SU; Cho HM; Das R; Gil-Henn H; Ramakrishnan S; Al Bayati A; Carroll SF; Zhang Y; Sankar AP; Elledge C; Pimentel A; Blonska M; Rosenblatt JD
Cells; 2021 Oct; 10(11):. PubMed ID: 34831127
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer.
Sun H; Yao N; Cheng S; Li L; Liu S; Yang Z; Shang G; Zhang D; Yao Z
Cancer Biol Med; 2019 May; 16(2):299-311. PubMed ID: 31516750
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
[TBL] [Abstract][Full Text] [Related]
9. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.
Liu TJ; Sun BC; Zhao XL; Zhao XM; Sun T; Gu Q; Yao Z; Dong XY; Zhao N; Liu N
Oncogene; 2013 Jan; 32(5):544-53. PubMed ID: 22469978
[TBL] [Abstract][Full Text] [Related]
10. Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells.
Maiti A; Qi Q; Peng X; Yan L; Takabe K; Hait NC
Int J Oncol; 2019 Jul; 55(1):116-130. PubMed ID: 31059004
[TBL] [Abstract][Full Text] [Related]
11. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
12. In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness.
Brugnoli F; Grassilli S; Piazzi M; Palomba M; Nika E; Bavelloni A; Capitani S; Bertagnolo V
Mol Cancer; 2013 Dec; 12():165. PubMed ID: 24330829
[TBL] [Abstract][Full Text] [Related]
13. CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy.
Nadal R; Ortega FG; Salido M; Lorente JA; Rodríguez-Rivera M; Delgado-Rodríguez M; Macià M; Fernández A; Corominas JM; García-Puche JL; Sánchez-Rovira P; Solé F; Serrano MJ
Int J Cancer; 2013 Nov; 133(10):2398-407. PubMed ID: 23661576
[TBL] [Abstract][Full Text] [Related]
14. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
[TBL] [Abstract][Full Text] [Related]
15. Effect of grape seed proanthocyanidins on tumor vasculogenic mimicry in human triple-negative breast cancer cells.
Luan YY; Liu ZM; Zhong JY; Yao RY; Yu HS
Asian Pac J Cancer Prev; 2015; 16(2):531-5. PubMed ID: 25684483
[TBL] [Abstract][Full Text] [Related]
16. Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.
Xiao T; Zhong W; Zhao J; Qian B; Liu H; Chen S; Qiao K; Lei Y; Zong S; Wang H; Liang Y; Zhang H; Meng J; Zhou H; Sun T; Liu Y; Yang C
Cell Death Dis; 2018 Sep; 9(9):906. PubMed ID: 30185783
[TBL] [Abstract][Full Text] [Related]
17. α-Linolenic acid inhibits the migration of human triple-negative breast cancer cells by attenuating Twist1 expression and suppressing Twist1-mediated epithelial-mesenchymal transition.
Wang SC; Sun HL; Hsu YH; Liu SH; Lii CK; Tsai CH; Liu KL; Huang CS; Li CC
Biochem Pharmacol; 2020 Oct; 180():114152. PubMed ID: 32679125
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2/Twist1 cooperation.
Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
Exp Mol Pathol; 2015 Oct; 99(2):383-91. PubMed ID: 26318343
[TBL] [Abstract][Full Text] [Related]
19. Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133
Brugnoli F; Grassilli S; Lanuti P; Marchisio M; Al-Qassab Y; Vezzali F; Capitani S; Bertagnolo V
BMC Cancer; 2017 Sep; 17(1):617. PubMed ID: 28870198
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.
Chinchar E; Makey KL; Gibson J; Chen F; Cole SA; Megason GC; Vijayakumar S; Miele L; Gu JW
Vasc Cell; 2014; 6():12. PubMed ID: 24914410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
